Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01104220 · ClinicalTrials.gov registry record · NA

Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk

A NA study of Obesity and Metabolic Syndrome, sponsored by Washington University School of Medicine.

Active
Registry status
NA
Development phase
144
Enrollment target
1
Study location

NCT01104220 is a NA study of Obesity and Metabolic Syndrome that is active but no longer recruiting, run by Washington University School of Medicine. The registered enrollment target is 144 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01104220, a NA study of Obesity and Metabolic Syndrome, is active but no longer recruiting, sponsored by Washington University School of Medicine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
144 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to learn more about how the body stores fat in and around organs (for example in the liver) and why this affects some people's health more than others. Understanding this may lead to better treatments for diseases such as diabetes and cardiovascular disease.

Interventions

  • OTHER Weight loss

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2010-04
Est. Completion 2026-12
Phase NA

What the Registry Record Tells You About NCT01104220

The ClinicalTrials.gov registry entry for NCT01104220 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Weight loss is the first listed.

NCT01104220 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT01104220 about?

NCT01104220 is a clinical study titled "Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk". The purpose of this study is to learn more about how the body stores fat in and around organs (for example in the liver) and why this affects some people's health more than others. Understanding this may lead to better treatments for diseases such as diabetes and cardiovascular disease.

What is the current status of trial NCT01104220?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2010-04. Estimated completion is 2026-12.

What conditions does trial NCT01104220 study?

This clinical trial studies the following conditions: Obesity, Metabolic Syndrome, Non-alcoholic Fatty Liver Disease, Metabolically Abnormal Obesity, Metabolically Normal Obesity.

What interventions are being tested in trial NCT01104220?

The interventions under investigation include: Weight loss (OTHER).

Who is sponsoring clinical trial NCT01104220?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01104220 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.